Treatment as Prevention ANRS 12249
South Africa, 2012 - 2016
Get Microdata
Reference ID
ANRS12249TasP
Producer(s)
Dabis, François, Newell, Marie-Louise, Pillay, Deenan
Collections
Metadata
Created on
Jan 30, 2018
Last modified
Jan 30, 2018
Page views
394627
Downloads
4610
- Data files
-
HIV Drug
Treatments - Households
- CHEs
-
Lab Test
Results -
ARTemis Lab
Results -
ARTemis
Patients -
CHE Adverse
Events - SCBs SCCs
-
CHE Action
Plans - Clusters
- Visits
- HHIs
- CFUs
- CFU Pill Tests
- Local Areas
- Census Rounds
- SCIs
-
Individual
Consents -
SAEs Initial
Notifications -
SAEs Initial
Notifications -
Events details -
SAEs Initial
Notifications -
Medications -
SAEs
Complementary
Notifications -
SAEs
Complementary
Notifications -
Medications - CBCs
- Specimens
- IQs
-
Minority
Variants - BMQ Surveys
- NGS Genomics
- Refusals
- NgsAssembQuality
- Sample Genomics
- Locations
- LinkToCareTracker
- Exits
-
ACCDB
Encounters -
ACCDB Encounter
Therapies - Individuals
- Trial Statuses
- DBS results
Adverse event symptom (AdvEventSymptom)
Data file: CHE Adverse Events
Overview
Valid:
695
Invalid:
0
Type:
Discrete
Decimal:
0
Width:
12
Range:
1 - 17
Format:
Numeric
Questions and instructions
Literal question
Since the last visit, or in last 6 months, have you experienced any symptoms which you feel are caused by your ART drugs?
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 1 | Nausea / vomiting | 22 |
3.2%
|
| 2 | Diarrhoea | 106 |
15.3%
|
| 3 | Loss of appetite | 69 |
9.9%
|
| 4 | Abdominal pain | 20 |
2.9%
|
| 5 | Jaundice | 4 |
0.6%
|
| 6 | Skin rash / itching | 101 |
14.5%
|
| 7 | Headache | 123 |
17.7%
|
| 8 | Dizziness | 28 |
4%
|
| 9 | Fatigue | 17 |
2.4%
|
| 10 | Insomnia | 3 |
0.4%
|
| 11 | Abnormal dreams | 6 |
0.9%
|
| 12 | Difficulty concentrating | 1 |
0.1%
|
| 13 | Painful feet | 102 |
14.7%
|
| 14 | Change in body shape | 64 |
9.2%
|
| 17 | Other | 29 |
4.2%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.